A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.

Disseminated Mycobacterium bovis is an uncommon side-effect of intravesical Bacillus Calmette-Guérin (BCG) therapy that may be mediated through Mycobacteraemia. This case report, of a 77-year-old man with a history of intravesical BCG therapy and recent cardiac surgery, highlights the need for patients with similar features on history, presenting with generalised symptoms, to have mycobacterial cultures included in their workup.

Internal medicine journal. 2017 Jul [Epub]

Alexander R L Robinson, Rajeswari Radhakrishnan, Robert Horvath, Sushil Pandey

School of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Department of Internal Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia., Department of Internal Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia., Queensland Mycobacterium Reference Laboratory, Pathology Queensland, Brisbane, Queensland, Australia.